Rebrozil subcutaneous injection 75mg by Bristol-Myers Squibb contains Ruspatercept (genetical recombination). This injectable drug, YJ code 3399417D2022, is supplied as 75mg per bottle and is indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell transfusions.
Rebrozil subcutaneous injection 75mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →